Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:01 AM ET 10-Q
Financial Results Fluor Corp FLR

Fluor Q3 2026 Results: Turns Profitable, Net Income $158M

Fluor Corporation reported a significant turnaround in the 2026 Quarter with net earnings attributable to Fluor of $158 million compared to a $697 million loss in the 2025 Quarter. The company benefited from a $197 million gain on the sale of its interest in ICA-Fluor and CFHI during the 2026 Period, while also executing a substantial $1.1 billion share repurchase program.

Key figure
Net income $158M
6:01 AM ET 10-Q
Financial Results Invesco DB Oil Fund DBO

Invesco DB Oil Fund Q3 2026 Results: Net Income $74M, Up 1749.4% YoY

For the nine months ended September 30, 2026, Invesco DB Oil Fund reported a significant net income of $188.5 million, a major recovery from a $7.1 million net loss in the prior year period. This growth was primarily driven by $136.0 million in realized gains and $46.8 million in unrealized appreciation from commodity futures contracts.

Key figure
Net income $74M · +1749.4% YoY
6:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice Tempest Therapeutics, Inc. TPST

Tempest Therapeutics Nasdaq/NYSE Compliance Notice

Tempest Therapeutics received a deficiency notice from Nasdaq on November 4, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until May 3, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. The notice has no immediate effect on the listing of the company's common stock.

Counterparty
Nasdaq
Term
180 days
6:01 AM ET 8-K
Loan & Debt Paid Inc PAYD

Paid $5.97M Debt Financing with Embolx, Inc.

PAID, Inc. has extended its Forbearance and Loan Modification Agreement with Embolx, Inc. through January 31, 2027. The agreement relates to a senior secured note with an outstanding balance of approximately $5.97 million that has been in periodic default. This extension allows the company to continue managing the debt obligation which carries a 25% interest rate.

Value
$5.97M
Counterparty
Embolx, Inc.
Term
through January 31, 2027
6:01 AM ET 10-Q
Financial Results Pershing Square Inc. PS

Pershing Square Q3 2026 Results: Net Loss of $19.9M

Pershing Square Inc. filed its 10-Q for the quarter ended September 30, 2026, following its IPO earlier in the year. The report highlights the company's transformation of HHH into a capital-light real estate platform and the planned launch of PSV, while noting risks related to investment performance and dependence on key personnel like William Ackman.

Key figure
Net loss $19.9M
6:01 AM ET 10-Q
Financial Results Invesco CurrencyShares Euro Trust FXE

Invesco CurrencyShares Euro Trust Q3 2026 Results: Net Income $856K, Down 12.3% YoY

Invesco CurrencyShares Euro Trust reported distributions of $0.24 per share for the quarter ended September 30, 2026, compared to $0.20 in the prior year period. The Trust's Euro principal balance decreased to 290,626,843 Euro (approximately $330.1 million USD) as of September 30, 2026, following significant redemption activity during the nine-month period.

Key figure
Net income $856K · -12.3% YoY
6:01 AM ET 10-Q
Financial Results Invesco DB Precious Metals Fund DBP

Invesco DB Precious Metals Fund Q3 2026 Results: Net Income $6.25M, Down 81.9% YoY

For the nine months ended September 30, 2026, the Fund reported a net loss of $20.8 million, a significant decline from the $70.6 million net income in the prior year period, primarily due to $33.8 million in unrealized losses on commodity futures. Shareholders' equity decreased to $219.4 million as of September 30, 2026, driven by both the net loss and a net decrease of $17.3 million from share redemptions.

Key figure
Net income $6.25M · -81.9% YoY
6:01 AM ET 8-K
Financial Results Sturm Ruger & Co Inc RGR

Sturm Ruger & Co Financial Results

Sturm, Ruger & Company reported third quarter 2026 net sales of $148 million, a 17% increase year-over-year. The company achieved improved profitability with adjusted EBITDA of $14 million and diluted earnings of $0.36 per share, driven by favorable product mix and manufacturing efficiencies. Management highlighted the implementation of a new Oracle Enterprise platform and portfolio decisions aimed at reducing complexity and aligning with long-term growth strategy.

Term
Q3 2026

“Our third quarter represented another meaningful step forward in executing our 2026 plan. We delivered another quarter of year-over-year and sequential sales growth while also improving profitability on both a year-over-year and sequential basis.”

Todd William Seyfert, President and CEO

“Net sales for the third quarter were $148 million, an increase of 17% compared with $127 million in the third quarter of 2025. Adjusted EBITDA for the quarter was $14 million compared with $3 million in the third quarter of 2025.”

Andrew Thomas Wieland, Senior VP & CFO
6:01 AM ET 10-Q
Financial Results Red River Bancshares Inc RRBI

Red River Bancshares Q3 2026 Results: Net Income $12.6M, Up 16.3% YoY

Red River Bancshares, Inc. reported total assets of $3.37 billion as of September 30, 2026, with a slight increase in loans held for investment to $2.32 billion. Stockholders' equity stood at $382.2 million, impacted by an accumulated other comprehensive loss of $58.1 million primarily related to the securities portfolio.

Key figure
Net income $12.6M · +16.3% YoY
6:01 AM ET 10-Q
Financial Results Avnet Inc AVT

Avnet Q1 2026 Results: Net Income $282M, Up 445.3% YoY

Avnet reported a significant increase in first-quarter sales to $10.72 billion for fiscal 2027, up from $5.90 billion in the prior year, with net income rising to $282.2 million. The company experienced substantial inventory growth and utilized $842.4 million in cash for operating activities, primarily driven by working capital requirements. Total assets increased to $18.47 billion as of October 3, 2026, supported by higher debt levels and accounts payable.

Key figure
Net income $282M · +445.3% YoY
6:01 AM ET 10-Q
Financial Results Invesco DB US Dollar Index Bullish Fund UUP

Invesco DB US Dollar Index Bullish Fund Q3 2026 Results: Net Income $4.6M, Up 9.9% YoY

For the nine months ended September 30, 2026, the Fund reported net income of $17.56 million, a significant recovery from a net loss of $24.46 million in the prior year period. This improvement was primarily driven by a $10.04 million net change in unrealized gains on currency futures contracts and increased dividend income from affiliates.

Key figure
Net income $4.6M · +9.9% YoY
6:01 AM ET 8-K
Financial Results Gran Tierra Energy Inc. GTE

Gran Tierra Energy Financial Results

Gran Tierra Energy reported its Q3 2026 financial results, highlighting average production of 39,904 BOEPD and a net loss of $42 million. The company is currently transitioning its portfolio, having received shareholder approval for the sale of its Colombian and Ecuadorian businesses while ratifying a new production sharing agreement in Azerbaijan.

Term
Q3 2026

“During the Quarter, we announced the sale of our Colombia and Ecuador businesses, received noteholder consent required to amend one of our indentures and subsequent to Quarter end, we received shareholder approval to proceed with the sale.”

Gary Guidry, President and Chief Executive Officer

“With $141 million of cash at quarter-end, we are well positioned as we work through the remaining approvals and conditions to closing, including regulatory approvals in Colombia and Ecuador. On closing, we expect to be debt-free, with the flexibility to return capital to stockholders and build our businesses in Canada and Azerbaijan.”

Gary Guidry, President and Chief Executive Officer
6:00 AM ET 10-Q
Financial Results 10x Genomics, Inc. TXG ▶ Call

10x Genomics Q3 2026 Results: Net Loss of $19.4M, Loss Narrows

10x Genomics, Inc. reported its third quarter 2026 results, highlighting continued revenue growth driven by its spatial biology and single-cell analysis platforms. The company maintained its full-year revenue guidance while noting improvements in gross margins due to manufacturing efficiencies.

Key figure
Net loss $19.4M
6:00 AM ET 10-Q
Financial Results Invesco CurrencyShares Swiss Franc Trust FXF

Invesco CurrencyShares Swiss Franc Trust Q3 2026 Results: Net Loss of $552K, Loss Narrows

The Trust reported an ending Swiss Franc principal balance of 312,796,324 (equivalent to $374,628,810 USD) as of September 30, 2026. The interest rate on deposits was negative 0.15%, and the Trust continues to operate as a single segment with a Sponsor's fee of 0.40% as its primary expense.

Key figure
Net loss $552K
6:00 AM ET 10-Q
Financial Results Invesco Galaxy Bitcoin ETF BTCO

Invesco Galaxy Bitcoin ETF Q3 2026 Results: Net Income $127M, Up 257.3% YoY

For the nine months ended September 30, 2026, the Trust reported a net loss of $56.3 million, driven by significant net realized losses on bitcoin sales and a decrease in total assets to $426.3 million from $544.4 million at year-end 2025. Net asset value per share declined from $87.22 to $83.09 during the period, reflecting a reduction in both the quantity of bitcoin held and its market valuation.

Key figure
Net income $127M · +257.3% YoY
6:00 AM ET 10-Q
Financial Results Allogene Therapeutics, Inc. ALLO

Allogene Therapeutics Q3 2026 Results: Net Loss of $50.4M, Loss Widens

Allogene Therapeutics reported a net loss of $50.4 million for the third quarter of 2026, an increase from the $41.4 million loss in the same period of 2025. The company strengthened its balance sheet through a public offering and ATM sales, ending the period with $392.6 million in total stockholders' equity compared to $292.5 million at the end of 2025.

Key figure
Net loss $50.4M
6:00 AM ET 10-Q
Financial Results Gran Tierra Energy Inc. GTE ▶ Call

Gran Tierra Energy Q3 2026 Results: Net Loss of $42.4M, Loss Widens

Gran Tierra Energy reported a net loss of $42.4 million for Q3 2026, compared to a $20.0 million loss in the prior year period, despite a 12.8% increase in oil and gas sales to $168.3 million. The increased loss was primarily driven by a significant $29.2 million loss on derivative instruments and higher general and administrative expenses.

Key figure
Net loss $42.4M
6:00 AM ET 10-Q
Financial Results Bill Holdings, Inc. BILL ▶ Call

Bill Holdings Q1 2026 Results: Turns Profitable, Net Income $60.3M

For the three months ended September 30, 2026, BILL Holdings reported total revenue of $353.8 million, an increase from $314.5 million in the prior year period. The company's balance sheet shows $4.13 billion in funds held for customers and a total stockholders' equity of $3.30 billion as of September 30, 2026.

Key figure
Net income $60.3M
9:53 PM ET Form 4
Insider Selling Ryerson Holding Corp RYZ

Ryerson Holding CEO Edward J. Lehner Sells $686K of Stock

Edward J. Lehner, CEO, sold 21,968 shares of Ryerson Holding Corp at $31.22 a share, worth $686K in total on Nov 4, 2026. Shares held after the trade: 623,596 (-3.4%).

Value
$686K
Shares
21,968
Price
$31.22
Role
CEO
Holding change
-3.4%
Trade date
Nov 4, 2026
9:06 PM ET Form 4
Insider Selling Landmark Bancorp Inc LARK

Landmark Bancorp Insider Patrick L. Alexander Sells $109K of Stock

Patrick L. Alexander sold 3,368 shares of Landmark Bancorp Inc at $32.50 a share, worth $109K in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 67,093 (-0.5%).

Value
$109K
Shares
3,368
Average price
$32.50
Holding change
-0.5%
Trade date
Nov 4, 2026 to Nov 5, 2026
9:06 PM ET Form 4
Insider Buying Grace Therapeutics, Inc. GRCE

Grace Therapeutics Insider Opaleye Management Inc. Buys $18.5K of Stock

Opaleye Management Inc. bought 10,328 shares of Grace Therapeutics, Inc. at $1.79 a share, worth $18.5K in total on Nov 3, 2026. Shares held after the trade: 3,046,739 (+0.3%).

Value
$18.5K
Shares
10,328
Price
$1.79
Holding change
+0.3%
Trade date
Nov 3, 2026
9:05 PM ET Form 4
Insider Selling Adma Biologics, Inc. ADMA

Adma Biologics President and CEO Adam S. Grossman Sells $1.76M of Stock

Adam S. Grossman, President and CEO, sold 147,000 shares of Adma Biologics, Inc. at $12.00 a share, worth $1.76M in total on Nov 5, 2026. Shares held after the trade: 2,070,777 (-2.0%).

Value
$1.76M
Shares
147,000
Average price
$12.00
Role
President and CEO
Holding change
-2.0%
Trade date
Nov 5, 2026
9:04 PM ET Form 4
Insider Selling MediaAlpha, Inc. MAX

MediaAlpha Insider White Mountains Insurance Group Ltd Sells $76.5M of Stock

White Mountains Insurance Group Ltd sold 5,500,391 shares of MediaAlpha, Inc. at $13.90 a share, worth $76.5M in total on Nov 4, 2026. Shares held after the trade: 12,356,223 (-30.8%).

Value
$76.5M
Shares
5,500,391
Price
$13.90
Holding change
-30.8%
Trade date
Nov 4, 2026
9:00 PM ET Form 4
Insider Buying Metallus Inc. MTUS

Metallus Director Ronald A. Rice Buys $166K of Stock

Ronald A. Rice, Director, bought 10,000 shares of Metallus Inc. at $16.61 a share, worth $166K in total on Nov 5, 2026. Shares held after the trade: 161,818 (+6.6%).

Value
$166K
Shares
10,000
Price
$16.61
Role
Director
Holding change
+6.6%
Trade date
Nov 5, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.